Equity

Treasury Stock

Synopsys Treasury Stock decreased by 51.8% to $191.85M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 77.7%, from $860.97M to $191.85M. Over 4 years (FY 2021 to FY 2025), Treasury Stock shows a downward trend with a -15.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.

Detailed definition

Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...

Peer comparison

Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.

Metric ID: treasury_stock

Historical Data

12 periods
 Q3 '21Q3 '22Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$782.87M$1.27B$1.68B$1.54B$1.32B$1.19B$1.03B$860.97M$689.00M$572.09M$398.28M$191.85M
QoQ Change+62.6%+31.6%-8.1%-14.1%-10.1%-13.7%-16.1%-20.0%-17.0%-30.4%-51.8%
YoY Change+62.6%+31.6%-38.8%-44.1%-47.9%-51.9%-61.2%-77.7%
Range$191.85M$1.68B
CAGR-40.0%
Avg YoY Growth-28.4%
Median YoY Growth-46.0%
Current Streak9 quarters decline

Frequently Asked Questions

What is Synopsys's treasury stock?
Synopsys (SNPS) reported treasury stock of $191.85M in Q4 2025.
How has Synopsys's treasury stock changed year-over-year?
Synopsys's treasury stock decreased by 77.7% year-over-year, from $860.97M to $191.85M.
What is the long-term trend for Synopsys's treasury stock?
Over 4 years (2021 to 2025), Synopsys's treasury stock has grown at a -15.5% compound annual growth rate (CAGR), from $782.87M to $398.28M.
What does treasury stock mean?
The value of shares a company has bought back from the market.